FutureChem Co Ltd
Company Profile
Business description
FutureChem Co Ltd is a radiopharmaceuticals company engaged in manufacturing related precursors chemicals, automatic synthesizer, and synthesis reagents and develops & commercializes new traces with research and development. It offers radiopharmaceuticals for diagnosing cancers, and Alzheimer's diseases; and automation modules and disposable goods, such as disposable cassettes, reagent kits, and radio-caps. It also provides peptide-based radiopharmaceuticals for radio-metal chelation and click reaction; linkers for bio-conjugation using copper-free/mediated click reaction. In addition, the company is involved in the research and development of radioisotope labeling technology; and automation devices. Further, it offers amino acids and reagents for peptides; and ionic liquids.
Contact
59, Seongsuil-ro
3rd Floor, B-dong, Pyeonghwa Building
Seoul04782
KORT: +82 24973114
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
89
Stocks News & Analysis
stocks
Undervalued ASX share with plan to mitigate tariff risk
stocks
Earnings up but shares overvalued for ASX gold miner
stocks
Alphabet: Anthropic deal and Gemini momentum stand to deliver; Fair Value up 27%
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,295.80 | 26.20 | -0.28% |
| CAC 40 | 8,211.44 | 27.74 | -0.34% |
| DAX 40 | 24,278.74 | 30.04 | -0.12% |
| Dow JONES (US) | 47,786.04 | 241.45 | 0.51% |
| FTSE 100 | 9,700.67 | 46.85 | 0.49% |
| HKSE | 26,346.14 | 87.56 | -0.33% |
| NASDAQ | 23,737.56 | 100.10 | 0.42% |
| Nikkei 225 | 50,219.18 | 293.14 | -0.58% |
| NZX 50 Index | 13,402.66 | 11.07 | 0.08% |
| S&P 500 | 6,881.35 | 6.19 | 0.09% |
| S&P/ASX 200 | 9,012.50 | 16.30 | -0.18% |
| SSE Composite Index | 3,988.22 | 8.72 | -0.22% |